CHARLOTTE, N.C., May 17, 2018 /PRNewswire/ -- SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, congratulates Naren Sanghvi on his receipt of The William and Francis Fry Honorary Fellowship for Contributions to Therapeutic Ultrasound, presented by The International Society for Therapeutic Ultrasound (ISTU).

CHARLOTTE, NC (PR NEWSWIRE) APRIL 05, 2018 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the enrollment of over 100 patients from the United States into the High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) Registry.

Medicare recognizes HIFU prostate ablation as a device-intensive procedure driving new ASC payment going into effect on or after October 1, 2017

CHARLOTTE, N.C., Sept. 20, 2017 /PRNewswire/ -- SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to announce an increase in Medicare payment for prostate HIFU ablation in the Ambulatory Surgical Center (ASC) setting. 

C-code goes into effect on July 1, 2017

affording greater opportunity to prostate patients in the United States

 

Charlotte, NC, May 23, 2017 – SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the imminent reimbursement for HIFU prostate tissue ablation with a newly approved C-code.

Page 1 of 10

HIFU company

Contact

10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384

info@SonaCareMedical.com

Mon - Fri: 9:00 - 5:00

Latest News

17 May 2018

CHARLOTTE, N.C., May 17, 2018 /PRNewswire/ -- SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, congratulates Naren Sanghvi on his receipt of The William...

10 April 2018

Over 120 urologists gather at Imperial College London to learn new diagnostic techniques and minimally invasive focal approaches for treating prostate cancer.